BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38386414)

  • 1. Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes.
    Luo Y; Feng X; Lang W; Xu W; Wang W; Mei C; Ye L; Zhu S; Wang L; Zhou X; Zeng H; Ma L; Ren Y; Jin J; Xu R; Huang G; Tong H
    J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38386414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patients with myelodysplastic syndrome.
    Genga KR; Filho FD; Ferreira FV; de Sousa JC; Studart FS; Magalhães SM; Heredia FF; Pinheiro RF
    J Clin Pathol; 2015 May; 68(5):381-7. PubMed ID: 25637637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB; Kadam NN
    Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
    Nolte F; Giehl M; Haass W; Nowak V; Schumann C; Nowak D; Mossner M; Popp HD; Schulze TJ; Klein S; Seifarth W; Hofmann WK; Fabarius A
    Ann Hematol; 2013 Oct; 92(10):1325-33. PubMed ID: 23645217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
    Jhanwar SC
    Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemic survival factor SALL4 contributes to defective DNA damage repair.
    Wang F; Gao C; Lu J; Tatetsu H; Williams DA; Müller LU; Cui W; Chai L
    Oncogene; 2016 Nov; 35(47):6087-6095. PubMed ID: 27132514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
    Roux B; Picou F; Debeissat C; Koubi M; Gallay N; Hirsch P; Ravalet N; Béné MC; Maigre M; Hunault M; Mosser J; Etcheverry A; Gyan E; Delhommeau F; Domenech J; Herault O
    Cancer Gene Ther; 2022 Aug; 29(8-9):1263-1275. PubMed ID: 35194200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
    Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
    Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
    Valcárcel D; Ademà V; Solé F; Ortega M; Nomdedeu B; Sanz G; Luño E; Cañizo C; de la Serna J; Ardanaz M; Marco V; Collado R; Grau J; Montoro J; Mallo M; Vallespí T
    J Clin Oncol; 2013 Mar; 31(7):916-22. PubMed ID: 23319689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis.
    Zemanova Z; Michalova K; Buryova H; Brezinova J; Kostylkova K; Bystricka D; Novakova M; Sarova I; Izakova S; Lizcova L; Ransdorfova S; Krejcik Z; Merkerova MD; Dohnalova A; Siskova M; Jonasova A; Neuwirtova R; Cermak J
    Leuk Res; 2014 May; 38(5):537-44. PubMed ID: 24636338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
    Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
    Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype.
    Wang W; Routbort MJ; Tang Z; Ok CY; Patel KP; Daver N; Garcia-Manero G; Medeiros LJ; Wang SA
    Eur J Haematol; 2017 Dec; 99(6):536-543. PubMed ID: 28926144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular pathogenesis of the myelodysplastic syndromes.
    Pellagatti A; Boultwood J
    Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
    Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
    PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of chromosome karyotype between myelodysplastic syndrome and acute leukemia patients confirmed at the same period].
    Jiang M; Wen BZ; Li L; Chen S; Cheng H; Hao JP; Chen R; Wang L; Zhao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):387-92. PubMed ID: 24763010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
    Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
    Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.
    Costa D; Muñoz C; Carrió A; Nomdedeu M; Calvo X; Solé F; Luño E; Cervera J; Vallespí T; Berneaga D; Gómez C; Arias A; Such E; Sanz G; Grau J; Insunza A; Calasanz MJ; Ardañaz MT; Hernández JM; Azaceta G; Álvarez S; Sánchez J; Martín ML; Bargay J; Gómez V; Cervero CJ; Allegue MJ; Collado R; Campo E; Nomdedeu B;
    Genes Chromosomes Cancer; 2013 Aug; 52(8):753-63. PubMed ID: 23686965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.